Literature DB >> 27185602

Associated factors in Streptococcus bovis bacteremia and colorectal cancer.

Cheng-En Tsai1, Cheng-Tang Chiu2, Christopher K Rayner3, Keng-Liang Wu4, Yi-Chun Chiu5, Ming-Luen Hu5, Seng-Kee Chuah5, Wei-Chen Tai5, Chih-Ming Liang5, Hsin-Ming Wang1.   

Abstract

Reports suggest that between 25% and 80% of patients with Streptococcus bovis/gallolyticus bacteremia have concomitant colorectal tumors. This retrospective study was aimed to identify associations between clinical characteristics and a finding of colorectal neoplasm in patients with S. bovis bacteremia who had colonoscopy examination. We retrospectively reviewed the records of patients with S. bovis bacteremia from Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, between January 2004 and January 2014. Clinical data including age, sex, comorbidities, blood culture, and colonoscopy findings were collected and their relationship to a finding of colorectal cancer was examined. A total of 107 patients with S. bovis bacteremia were identified, of whom 49 (72% male; age 65 ± 12 years) were investigated with colonoscopy; 15 of these patients (30.6%) had colorectal adenocarcinoma. Female sex (p = 0.014) and a history of noncolorectal malignancy (p = 0.004) were associated with a finding of colorectal adenocarcinoma. There were no associations with age, percentage of blood cultures, or the presence of diabetes mellitus, chronic liver disease, heart disease, or end-stage renal disease. Our results show that S. bovis bacteremia is associated with the presence of colorectal adenocarcinoma, especially in female patients, and concomitant existence of other malignancies.
Copyright © 2016. Published by Elsevier Taiwan.

Entities:  

Keywords:  Bacteremia; Colorectal adenocarcinoma; Streptococcus bovis

Mesh:

Year:  2016        PMID: 27185602     DOI: 10.1016/j.kjms.2016.03.003

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  13 in total

1.  Systematic review: Gut microbiota in fecal samples and detection of colorectal neoplasms.

Authors:  Efrat L Amitay; Agne Krilaviciute; Hermann Brenner
Journal:  Gut Microbes       Date:  2018-05-15

Review 2.  Role of intestinal flora in colorectal cancer from the metabolite perspective: a systematic review.

Authors:  Shuwen Han; Jianlan Gao; Qing Zhou; Shanshan Liu; Caixia Wen; Xi Yang
Journal:  Cancer Manag Res       Date:  2018-01-31       Impact factor: 3.989

Review 3.  Fusobacterium nucleatum and colorectal cancer: A review.

Authors:  Fu-Mei Shang; Hong-Li Liu
Journal:  World J Gastrointest Oncol       Date:  2018-03-15

4.  Infectious Endocarditis from Enterococcus faecalis Associated with Tubular Adenoma of the Sigmoid Colon.

Authors:  Emilly Caroline de Freitas Silva; Camila Ronchini Montalvão; Simone Bonafé
Journal:  Case Rep Infect Dis       Date:  2017-08-07

5.  Disseminated Streptococcus bovis infection after consumption of manatee meat: A case report and review of the literature.

Authors:  Dahyana Cadavid Aljure; Verónica Posada-Vélez; Laura Betancur Vásquez; Juan Sebastián Gómez Villalobos; Juan Pablo Villa Franco; Juan Carlos Tobón Pereira; María Alejandra Muñoz Cifuentes; José Nelson Carvajal
Journal:  IDCases       Date:  2020-07-15

Review 6.  The Complex Puzzle of Interactions Among Functional Food, Gut Microbiota, and Colorectal Cancer.

Authors:  Lígia A B M Mendonça; Rosângela Dos Santos Ferreira; Rita de Cássia Avellaneda Guimarães; Alinne P de Castro; Octávio L Franco; Rosemary Matias; Cristiano M E Carvalho
Journal:  Front Oncol       Date:  2018-09-05       Impact factor: 6.244

7.  Gut microbiome associated with chemotherapy-induced diarrhea from the CapeOX regimen as adjuvant chemotherapy in resected stage III colorectal cancer.

Authors:  Zuo Fei; Yin Lijuan; Yang Xi; Wu Wei; Zhong Jing; Da Miao; Han Shuwen
Journal:  Gut Pathog       Date:  2019-04-30       Impact factor: 4.181

Review 8.  Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy.

Authors:  Kumar Ganesan; Songhe Guo; Sundaz Fayyaz; Ge Zhang; Baojun Xu
Journal:  Cancers (Basel)       Date:  2019-10-18       Impact factor: 6.639

Review 9.  Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?

Authors:  Samira Tarashi; Seyed Davar Siadat; Sara Ahmadi Badi; Mohammadreza Zali; Roberto Biassoni; Mirco Ponzoni; Arfa Moshiri
Journal:  Microorganisms       Date:  2019-11-13

Review 10.  Colorectal cancer: The epigenetic role of microbiome.

Authors:  Hussein Sabit; Emre Cevik; Huseyin Tombuloglu
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.